United States Veterinary/Animal Vaccines Market Report 2017

July 2017 | 98 pages | ID: U292ACE71BCEN
QYResearch

Abstracts

In this report, the United States Veterinary/Animal Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Veterinary/Animal Vaccines in these regions, from 2012 to 2022 (forecast).

United States Veterinary/Animal Vaccines market competition by top manufacturers/players, with Veterinary/Animal Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Zoetis Inc. (Pfizer) (U.S.)
• Merck Animal Health (Germany)
• Merial Inc. (China)
• Boehringer Ingelheim (Germany)
• Bayer Animal Health (Germany)
• Elanco Animal Health (U.S.)
• Ceva Animal Health
• Heska Corporation (U.S.)
• Virbac Inc. (France)
• Bioniche Animal Health (Canada)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Product
• Livestock Vaccines
• Companion Animal Vaccines
• Porcine Vaccines
• Equine Vaccines
• Poultry Vaccines
• Aquaculture Vaccines
• Other Animal Vaccines
• By Technology
• Inactivated Vaccines
• Live Attenuated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• DNA Vaccines
• Conjugate Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Veterinary/Animal Vaccines for each application, including

• Livestock Diseases
• Aquaculture Diseases
• Poultry Diseases
• Companion Animal Diseases
• Equine Diseases
• Porcine Diseases
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Veterinary/Animal Vaccines Market Report 2017

1 VETERINARY/ANIMAL VACCINES OVERVIEW

1.1 Product Overview and Scope of Veterinary/Animal Vaccines
1.2 Classification of Veterinary/Animal Vaccines by Product Category
  1.2.1 United States Veterinary/Animal Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Veterinary/Animal Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Livestock Vaccines
  1.2.4 Companion Animal Vaccines
  1.2.5 Porcine Vaccines
  1.2.6 Equine Vaccines
  1.2.7 Poultry Vaccines
  1.2.8 Aquaculture Vaccines
  1.2.9 Other Animal Vaccines
1.3 United States Veterinary/Animal Vaccines Market by Application/End Users
  1.3.1 United States Veterinary/Animal Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Livestock Diseases
  1.3.3 Aquaculture Diseases
  1.3.4 Poultry Diseases
  1.3.5 Companion Animal Diseases
  1.3.6 Equine Diseases
  1.3.7 Porcine Diseases
  1.3.8 Other
1.4 United States Veterinary/Animal Vaccines Market by Region
  1.4.1 United States Veterinary/Animal Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Veterinary/Animal Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest Veterinary/Animal Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Veterinary/Animal Vaccines Status and Prospect (2012-2022)
  1.4.5 New England Veterinary/Animal Vaccines Status and Prospect (2012-2022)
  1.4.6 The South Veterinary/Animal Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest Veterinary/Animal Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Veterinary/Animal Vaccines (2012-2022)
  1.5.1 United States Veterinary/Animal Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States Veterinary/Animal Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES VETERINARY/ANIMAL VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Veterinary/Animal Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Veterinary/Animal Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Veterinary/Animal Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Veterinary/Animal Vaccines Market Competitive Situation and Trends
  2.4.1 United States Veterinary/Animal Vaccines Market Concentration Rate
  2.4.2 United States Veterinary/Animal Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Veterinary/Animal Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES VETERINARY/ANIMAL VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Veterinary/Animal Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Veterinary/Animal Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Veterinary/Animal Vaccines Price by Region (2012-2017)

4 UNITED STATES VETERINARY/ANIMAL VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Veterinary/Animal Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Veterinary/Animal Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Veterinary/Animal Vaccines Price by Type (2012-2017)
4.4 United States Veterinary/Animal Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES VETERINARY/ANIMAL VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Veterinary/Animal Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Veterinary/Animal Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES VETERINARY/ANIMAL VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Zoetis Inc. (Pfizer) (U.S.)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Veterinary/Animal Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Zoetis Inc. (Pfizer) (U.S.) Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck Animal Health (Germany)
  6.2.2 Veterinary/Animal Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Animal Health (Germany) Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merial Inc. (China)
  6.3.2 Veterinary/Animal Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merial Inc. (China) Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim (Germany)
  6.4.2 Veterinary/Animal Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Boehringer Ingelheim (Germany) Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bayer Animal Health (Germany)
  6.5.2 Veterinary/Animal Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bayer Animal Health (Germany) Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Elanco Animal Health (U.S.)
  6.6.2 Veterinary/Animal Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Elanco Animal Health (U.S.) Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Ceva Animal Health
  6.7.2 Veterinary/Animal Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Ceva Animal Health Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Heska Corporation (U.S.)
  6.8.2 Veterinary/Animal Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Heska Corporation (U.S.) Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Virbac Inc. (France)
  6.9.2 Veterinary/Animal Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Virbac Inc. (France) Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Bioniche Animal Health (Canada)
  6.10.2 Veterinary/Animal Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Bioniche Animal Health (Canada) Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 VETERINARY/ANIMAL VACCINES MANUFACTURING COST ANALYSIS

7.1 Veterinary/Animal Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Veterinary/Animal Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Veterinary/Animal Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Veterinary/Animal Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Veterinary/Animal Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Veterinary/Animal Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Veterinary/Animal Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Veterinary/Animal Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Veterinary/Animal Vaccines
Figure United States Veterinary/Animal Vaccines Market Size (K Units) by Type (2012-2022)
Figure United States Veterinary/Animal Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Livestock Vaccines Product Picture
Figure Companion Animal Vaccines Product Picture
Figure Porcine Vaccines Product Picture
Figure Equine Vaccines Product Picture
Figure Poultry Vaccines Product Picture
Figure Aquaculture Vaccines Product Picture
Figure Other Animal Vaccines Product Picture
Figure United States Veterinary/Animal Vaccines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Veterinary/Animal Vaccines by Application in 2016
Figure Livestock Diseases Examples
Table Key Downstream Customer in Livestock Diseases
Figure Aquaculture Diseases Examples
Table Key Downstream Customer in Aquaculture Diseases
Figure Poultry Diseases Examples
Table Key Downstream Customer in Poultry Diseases
Figure Companion Animal Diseases Examples
Table Key Downstream Customer in Companion Animal Diseases
Figure Equine Diseases Examples
Table Key Downstream Customer in Equine Diseases
Figure Porcine Diseases Examples
Table Key Downstream Customer in Porcine Diseases
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Veterinary/Animal Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Veterinary/Animal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Veterinary/Animal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Veterinary/Animal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Veterinary/Animal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Veterinary/Animal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Veterinary/Animal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Veterinary/Animal Vaccines Sales (K Units) and Growth Rate (2012-2022)
Figure United States Veterinary/Animal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Veterinary/Animal Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Veterinary/Animal Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Veterinary/Animal Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Veterinary/Animal Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Veterinary/Animal Vaccines Sales Share by Players/Suppliers
Figure United States Veterinary/Animal Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Veterinary/Animal Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Veterinary/Animal Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Veterinary/Animal Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Veterinary/Animal Vaccines Revenue Share by Players/Suppliers
Table United States Market Veterinary/Animal Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Veterinary/Animal Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Veterinary/Animal Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Veterinary/Animal Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Veterinary/Animal Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Veterinary/Animal Vaccines Product Category
Table United States Veterinary/Animal Vaccines Sales (K Units) by Region (2012-2017)
Table United States Veterinary/Animal Vaccines Sales Share by Region (2012-2017)
Figure United States Veterinary/Animal Vaccines Sales Share by Region (2012-2017)
Figure United States Veterinary/Animal Vaccines Sales Market Share by Region in 2016
Table United States Veterinary/Animal Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Veterinary/Animal Vaccines Revenue Share by Region (2012-2017)
Figure United States Veterinary/Animal Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Veterinary/Animal Vaccines Revenue Market Share by Region in 2016
Table United States Veterinary/Animal Vaccines Price (USD/Unit) by Region (2012-2017)
Table United States Veterinary/Animal Vaccines Sales (K Units) by Type (2012-2017)
Table United States Veterinary/Animal Vaccines Sales Share by Type (2012-2017)
Figure United States Veterinary/Animal Vaccines Sales Share by Type (2012-2017)
Figure United States Veterinary/Animal Vaccines Sales Market Share by Type in 2016
Table United States Veterinary/Animal Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Veterinary/Animal Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Veterinary/Animal Vaccines by Type (2012-2017)
Figure Revenue Market Share of Veterinary/Animal Vaccines by Type in 2016
Table United States Veterinary/Animal Vaccines Price (USD/Unit) by Types (2012-2017)
Figure United States Veterinary/Animal Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Veterinary/Animal Vaccines Sales (K Units) by Application (2012-2017)
Table United States Veterinary/Animal Vaccines Sales Market Share by Application (2012-2017)
Figure United States Veterinary/Animal Vaccines Sales Market Share by Application (2012-2017)
Figure United States Veterinary/Animal Vaccines Sales Market Share by Application in 2016
Table United States Veterinary/Animal Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Veterinary/Animal Vaccines Sales Growth Rate by Application (2012-2017)
Table Zoetis Inc. (Pfizer) (U.S.) Basic Information List
Table Zoetis Inc. (Pfizer) (U.S.) Veterinary/Animal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Zoetis Inc. (Pfizer) (U.S.) Veterinary/Animal Vaccines Sales Growth Rate (2012-2017)
Figure Zoetis Inc. (Pfizer) (U.S.) Veterinary/Animal Vaccines Sales Market Share in United States (2012-2017)
Figure Zoetis Inc. (Pfizer) (U.S.) Veterinary/Animal Vaccines Revenue Market Share in United States (2012-2017)
Table Merck Animal Health (Germany) Basic Information List
Table Merck Animal Health (Germany) Veterinary/Animal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Animal Health (Germany) Veterinary/Animal Vaccines Sales Growth Rate (2012-2017)
Figure Merck Animal Health (Germany) Veterinary/Animal Vaccines Sales Market Share in United States (2012-2017)
Figure Merck Animal Health (Germany) Veterinary/Animal Vaccines Revenue Market Share in United States (2012-2017)
Table Merial Inc. (China) Basic Information List
Table Merial Inc. (China) Veterinary/Animal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merial Inc. (China) Veterinary/Animal Vaccines Sales Growth Rate (2012-2017)
Figure Merial Inc. (China) Veterinary/Animal Vaccines Sales Market Share in United States (2012-2017)
Figure Merial Inc. (China) Veterinary/Animal Vaccines Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Veterinary/Animal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim (Germany) Veterinary/Animal Vaccines Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim (Germany) Veterinary/Animal Vaccines Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim (Germany) Veterinary/Animal Vaccines Revenue Market Share in United States (2012-2017)
Table Bayer Animal Health (Germany) Basic Information List
Table Bayer Animal Health (Germany) Veterinary/Animal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Animal Health (Germany) Veterinary/Animal Vaccines Sales Growth Rate (2012-2017)
Figure Bayer Animal Health (Germany) Veterinary/Animal Vaccines Sales Market Share in United States (2012-2017)
Figure Bayer Animal Health (Germany) Veterinary/Animal Vaccines Revenue Market Share in United States (2012-2017)
Table Elanco Animal Health (U.S.) Basic Information List
Table Elanco Animal Health (U.S.) Veterinary/Animal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Elanco Animal Health (U.S.) Veterinary/Animal Vaccines Sales Growth Rate (2012-2017)
Figure Elanco Animal Health (U.S.) Veterinary/Animal Vaccines Sales Market Share in United States (2012-2017)
Figure Elanco Animal Health (U.S.) Veterinary/Animal Vaccines Revenue Market Share in United States (2012-2017)
Table Ceva Animal Health Basic Information List
Table Ceva Animal Health Veterinary/Animal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ceva Animal Health Veterinary/Animal Vaccines Sales Growth Rate (2012-2017)
Figure Ceva Animal Health Veterinary/Animal Vaccines Sales Market Share in United States (2012-2017)
Figure Ceva Animal Health Veterinary/Animal Vaccines Revenue Market Share in United States (2012-2017)
Table Heska Corporation (U.S.) Basic Information List
Table Heska Corporation (U.S.) Veterinary/Animal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Heska Corporation (U.S.) Veterinary/Animal Vaccines Sales Growth Rate (2012-2017)
Figure Heska Corporation (U.S.) Veterinary/Animal Vaccines Sales Market Share in United States (2012-2017)
Figure Heska Corporation (U.S.) Veterinary/Animal Vaccines Revenue Market Share in United States (2012-2017)
Table Virbac Inc. (France) Basic Information List
Table Virbac Inc. (France) Veterinary/Animal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Virbac Inc. (France) Veterinary/Animal Vaccines Sales Growth Rate (2012-2017)
Figure Virbac Inc. (France) Veterinary/Animal Vaccines Sales Market Share in United States (2012-2017)
Figure Virbac Inc. (France) Veterinary/Animal Vaccines Revenue Market Share in United States (2012-2017)
Table Bioniche Animal Health (Canada) Basic Information List
Table Bioniche Animal Health (Canada) Veterinary/Animal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bioniche Animal Health (Canada) Veterinary/Animal Vaccines Sales Growth Rate (2012-2017)
Figure Bioniche Animal Health (Canada) Veterinary/Animal Vaccines Sales Market Share in United States (2012-2017)
Figure Bioniche Animal Health (Canada) Veterinary/Animal Vaccines Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Veterinary/Animal Vaccines
Figure Manufacturing Process Analysis of Veterinary/Animal Vaccines
Figure Veterinary/Animal Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Veterinary/Animal Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Veterinary/Animal Vaccines
Table Distributors/Traders List
Figure United States Veterinary/Animal Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Veterinary/Animal Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Veterinary/Animal Vaccines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Veterinary/Animal Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Veterinary/Animal Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Veterinary/Animal Vaccines Sales Volume (K Units) Forecast by Type in 2022
Table United States Veterinary/Animal Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Veterinary/Animal Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Veterinary/Animal Vaccines Sales Volume (K Units) Forecast by Application in 2022
Table United States Veterinary/Animal Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Veterinary/Animal Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Veterinary/Animal Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Veterinary/Animal Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources